Skip to content

Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults

Evaluation of the Performance of Contour Next® and Contour Plus Elite® Blood Glucose Monitoring Systems (BGMS) in Arterial Blood Samples From Hospitalized Adults

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05449795
Enrollment
120
Registered
2022-07-08
Start date
2022-11-29
Completion date
2023-04-20
Last updated
2025-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.

Detailed description

This trial will evaluate the performance of both Contour Next BGMS and Contour Plus Elite BGMS using arterial blood from adult patients hospitalized in a Critical Care Unit (medical and surgical intensive care units (ICUs)). The investigational BGMS will be tested by a Point-of-Care (POC) operator in a clinical setting using residual arterial blood samples from adults who underwent prescribed arterial blood tests that were deemed necessary due to their medical conditions.

Interventions

DEVICEDevice: Contour Next and Contour Plus Elite BGMS testing of arterial blood

The purpose of the study is to extend the intended use of two BGMSs to include testing of arterial blood by Health Care Professionals (HCP) in a clinical setting.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients who are at least 18 years old. * Residual Arterial blood samples collected from subjects hospitalized in a Critical Care Unit (medical and surgical intensive care units (ICUs)). * Sample blood volume must be sufficient to complete investigational testing procedures clinical laboratory testing.

Exclusion criteria

\- Residual arterial blood samples collected from subjects previously enrolled. and evaluated for this study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values1 dayAt least 95% of all blood glucose results shall fall within ±12.5% of reference values (laboratory method) for glucose concentration ≥100 mg/dL(5.55 mmol/L )and within ±12 mg/dL(±0.67 mmol/L) at glucose concentrations \<100 mg/dL(5.55 mmol/L).
Number of Results From the Contour Plus Elite BGMSs Reference Values Within ±12.5% of Reference Values1 dayAt least 98% of values should be within ±12.5% of reference values (laboratory method) for glucose concentration ≥75 mg/dL(4.16 mmol/L) and within ±15 mg/dL(±0.83 mmol/L) at glucose concentrations \< 75 mg/dL(4.16 mmol/L).

Countries

Australia

Participant flow

Participants by arm

ArmCount
Arterial Blood Results
Samples collected and tested in duplicate by BGMS and compared to laboratory results
120
Arterial Blood Results
Samples collected and tested in duplicate by BGMS and compared to laboratory results
240
Total360

Baseline characteristics

CharacteristicArterial Blood Results
Age, Continuous59.2 years
STANDARD_DEVIATION 16.1
Region of Enrollment
Australia
120 participants
Sex: Female, Male
Female
39 Participants
Sex: Female, Male
Male
81 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 120
other
Total, other adverse events
0 / 120
serious
Total, serious adverse events
0 / 120

Outcome results

Primary

Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values

At least 95% of all blood glucose results shall fall within ±12.5% of reference values (laboratory method) for glucose concentration ≥100 mg/dL(5.55 mmol/L )and within ±12 mg/dL(±0.67 mmol/L) at glucose concentrations \<100 mg/dL(5.55 mmol/L).

Time frame: 1 day

Population: arterial samples

ArmMeasureValue (COUNT_OF_UNITS)
Arterial Blood ResultsNumber of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values236 blood samples
Primary

Number of Results From the Contour Plus Elite BGMSs Reference Values Within ±12.5% of Reference Values

At least 98% of values should be within ±12.5% of reference values (laboratory method) for glucose concentration ≥75 mg/dL(4.16 mmol/L) and within ±15 mg/dL(±0.83 mmol/L) at glucose concentrations \< 75 mg/dL(4.16 mmol/L).

Time frame: 1 day

Population: Arterial samples tested.

ArmMeasureValue (COUNT_OF_UNITS)
Arterial Blood ResultsNumber of Results From the Contour Plus Elite BGMSs Reference Values Within ±12.5% of Reference Values240 blood samples

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026